Gaorong Capital and CTS Capital led a more than CNY500m (~USD74m) Series C for Intellective Biologics (Zhixiang Bio), a China-based contract development and manufacturing organization that focuses on macromolecular biopharma process development, with follow-on from Fuho Capital, CNCB Investment Limited, Founder Securities, Win Harbor Capital and others.Read… Read More
India-based fintech CRED acquired Smallcase, an India-based wealth management platform backed by Blume Ventures, Sequoia Capital, Amazon and others, for ~USD400m. Smallcase raised USD140m at a reported USD6.4b valuation in June as part of its Series F round led by GIC. Read more… Read More
Singularity Ventures, through its Growth Opportunities Fund, and SWC Global led a USD20m Series B for WebEngage, an India-based full-stack CRM platform, with participation from Unmaj Corporation, NB Ventures, Shashwat Nakrani (BharatPe) and Gopal Srinivasan (TVS Capital), and follow-on from India Quotient, Blume Ventures and Indian Angel Network’s IAN Fund. Read More
Sarmayacar and Shorooq Partners led a USD11m round for OneLoad, a Pakistan-based logistics and fintech platform serving micro-retailers and run by EP Systems. The Bill and Melinda Gates Foundation invested in OneLoad in November 2021, and IFC invested in 2020. Read more… Read More
Suzhou Ribo Life Science, a China-based clinical-stage biotech with a focus on nucleic acid research,raised USD40m in the first tranche of a Series E led by Panlin Capital and Sany Foundation’s Trinity Innovation Fund, with participation from new investors. The startup raised a CNY673m (~USD95m) Series C in 2020 from… Read More
Yunfeng Capital and Gaorong Capital led a USD200m Series B for Sironax, a China-based clinical-stage biotech with a focus on the treatment of age-related degenerative disease, with participation from MSA Capital, a subsidiary of Abu Dhabi Investment Authority (ADIA), CBC Group, Long River Investments, LSV Capital, Superstring Capital and Future… Read More
Qiming Venture Partners led a USD22m Series A extension round for GluBio Therapeutics, a US- and China-based biotech focused on developing targeted protein degradation (TPD) drugs, with follow-on from Lilly Asia Ventures and Kaitai Capital. Read more… Read More
Insignia Ventures Partners reached a USD516m final close for its third venture fund. The vehicle invests in early-stage Southeast Asian startups. Read more… Read More
India-based rural fintech Jai Kisan raised USD50m in equity and debt in the first tranche of its Series B round at a reported USD200-240m valuation. GMO Venture Partners, Yara Growth Ventures and DG Daiwa Ventures, as well as existing investors Blume Ventures, Arkam Ventures, Mirae Asset Capital and Snow Leopard… Read More
Carlyle and Advent International each agreed to acquire up to a 10% stake in India-listed commercial bank YES BANK for a combined USD1.1b. The deal includes USD640m in equity shares and USD475m in warrants. Read more here, here and… Read More
(default archive template)